qCON/qNOX-Guided Anesthesia in Patients Undergoing Thyroidectomy Surgery
The Effect of qCON/qNOX-Guided Anesthesia Using the Conox Monitor on Clinical Outcomes in Patients Undergoing Thyroidectomy Surgery
Kayseri City Hospital
90 participants
Apr 10, 2026
INTERVENTIONAL
Conditions
Summary
The aim of this study is to evaluate the effect of using the non-invasive Conox monitor on intraoperative opioid consumption. Additionally, the study aims to assess the impact of Conox monitoring on recovery time, postoperative agitation rate, and pain scores, and to investigate the correlation between qCON and qNOX values and conventional hemodynamic parameters.
Eligibility
Inclusion Criteria3
- Patients aged 18-70 years
- Thyroidectomy cases with ASA physical status I-II
- Patients who have provided written informed consent
Exclusion Criteria3
- Skin lesions preventing EEG electrode placement
- Neurological disorders (e.g., epilepsy)
- Anticipated difficult airway
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Conox EEG monitor will be applied intraoperatively. Anesthetic and opioid titration will be guided by qCON values between 40-60 and qNOX values between 30-60. Opioid administration will be adjusted according to qNOX levels in addition to standard clinical monitoring.
Standard anesthesia management will be performed according to routine clinical practice. Opioid titration will be guided by conventional hemodynamic parameters including heart rate and mean arterial pressure. No EEG-based monitoring will be used for analgesia titration.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07445659